Ahmad Abu-Ghazaleh - Dec 9, 2022 Form 4 Insider Report for FRESH DEL MONTE PRODUCE INC (FDP)

Role
Director
Signature
/s/ Effie D. Silva, Attorney-in-Fact for Ahmad Abu-Ghazaleh
Stock symbol
FDP
Transactions as of
Dec 9, 2022
Transactions value $
$0
Form type
4
Date filed
12/13/2022, 04:36 PM
Previous filing
Sep 13, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FDP Ordinary Shares 30.3K Dec 9, 2022 Direct
holding FDP Ordinary Shares 40K Dec 9, 2022 Held By Children

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDP Dividend Equivalent Units Award $0 +33.2 +96.27% $0.00 67.8 Dec 9, 2022 Ordinary Shares 33.2 Direct F1, F2
holding FDP Restricted Stock Units 5.9K Dec 9, 2022 Ordinary Shares 5.9K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate.
F2 Reflects DEUs received by the Reporting Person as a result of dividend equivalents accrued with respect to outstanding RSUs granted to the Reporting Person. Dividend equivalents are accrued at the same rate and at the same time as dividends are paid to Ordinary Shareholders. Dividend equivalents on RSUs are subject to the same restrictions and vesting conditions as the underlying RSUs.
F3 The RSUs convert to Ordinary Shares on a one-for-one basis.
F4 Represents a grant of RSUs for board service for the 2022-2023 term. These restricted stock units shall vest on the earlier of: (i) the one-year anniversary of the grant date; and (ii) the date of the next annual meeting of the shareholders of the issuer that follows the grant date.